Tumor samples with defective BRCA2 display the defined HR-defective mutational signature 3 with single-base substitutions (SBSs), ID6 with small insertions and deletions, and structural variants with non-clustered deletions < 100 kb and reciprocal translocations [133,134,135,136,137]. This evidence concerns the gene BRCA2 and neoplasm.